1. Amfo K, Neyns B, Teugels E, Lissens W, Bourgain C, de Sutter P, Vandamme B, Vamos E, de Greve J (1995) Frequent deletion of chromosome 19 and a rare rearrangement of 19p13. 3 involving the insulin receptor gene in human ovarian cancer. Oncogene 11:351–358
2. Balaj L, Atai NA, Chen W, Mu D, Tannous BA, Breakefield XO, Skog J, Maguire CAJSR (2015) Heparin affinity purification of extracellular vesicles. 5:10266
3. Bicher A, Ault K, Kimmelman A, Gershenson D, Reed E, Liang B (1997) Loss of heterozygosity in human ovarian cancer on chromosome 19q. Gynecologic oncology 66:36–40
4. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC ,Macdonald DR, Ino Y (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. JNCI: J Natl Cancer Inst 90:1473–1479
5. Chen J, Chen T, Zhu Y, Li Y, Zhang Y, Wang Y, Li X, Xie X, Wang J, Huang M (2019) circPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma. Journal of experimental & clinical cancer research 38:1–17